This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Barbui T, Ghirardi A, Masciulli A, Carobbio A, Palandri F, Vianelli N, et al. Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study. Leukemia. 2019;33(May 29):1996–2005.
Landolfi R, Marchioli R, Kutti J, Gisslinger H, Tognoni G, Patrono C, et al. Efficacy and safety of low-dose aspirin in polycythemia vera. New Engl J Med. 2004;350(Jan 8):114–24.
Bardou M, Barkun AN, Martel M, Chapelle N. Sa2019—chemoprevention of colorectal cancer in the general population: an umbrella metaanalysis. Gastroenterology. 2019;156:S–472.
McNeil JJ, Nelson MR, Woods RL, Lockery JE, Wolfe R, Reid CM, et al. Effect of aspirin on all-cause mortality in the healthy elderly. New Engl J Med. 2018;379:1519–1528.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lucijanic, M., Skelin, M. & Kusec, R. Second primary malignancies in myeloproliferative neoplasms and the role of aspirin. Leukemia 33, 2554 (2019). https://doi.org/10.1038/s41375-019-0553-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-019-0553-2